Investigation of Pharmacia UniCAP 100 for in vitro allergy diagnosis

Clinical Laboratory

Volumn 45, Issue 5-6, 1999, Pages 229-235

  Liappis, Nicolas ^a   Starke, Astrit ^a   Lantto, Olle ^b   Rydén, Birgitta ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b PFIZER INC   (United States)

Author keywords

Evaluation; FEIA; Specific IgE; Total IgE; UniCAP 100

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY;

ACCURACY; ALLERGY; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; QUALITY CONTROL; TECHNIQUE;

EID: 0032980261     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Anderson HR. Increased hospital admissions for childhood asthma: trends in referral, seventy, and readmissions from 1970 to 1985 in a health region of the United Kingdom. Thorax 1989; 44: 614-619.
2. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth. BMJ 1990; 300: 1306-1310.
3. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64: 1452-1456.
4. Johansson SGO. Allergology before and with IgE. Annual Meeting of the European Academy of Allergology and Clinical Immunology, 1.-5. June 1997, Rhodes - Hellas.
5. Liappis N, Schlebusch H, Brockow E. Referenzbereiche für die IgE-Konzentration im Serum von Erwachsenen. Methode: ImmunoCAP-System. Diagnostica Nachrichten 1990; 9: 10-11.
6. Liappis N, Starke A, Mallmann R. In-vitro-Allergiescreening mit Hilfe des Pharmacia-CAP-IgE-Tests, des SXI-Tests auf inhalative Allergene und des fx5-Tests auf Nahrungsminelallergene. Atopieinzidenz im Kindesalter. Monatsschr Kinderheilkd 1996; 144: 271-274.
7. Rieger C, Riedel F. Umweltveränderungen und Allergieentstehung. Kinderarzt 1991; 22: 258-259.
8. Taylor B, Wadsworth J, Wadsworth M, Peckham C. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984; II: 1255-1257.
9. Wüthrich B. Epidemiology of the allergic diseases: are they really in the increase? Int Arch Allergy Immunol 1989; 90: 3-10.
10. Zetterström O. The increased prevalence of allergic airway disease. Allergy 1988; 43: 10-11.
11. Bergmann RL, Bergmann KE, Forster Z, Bauer CP, Schmidt E, Lau-Schadendorf S, Wahn U. Atopische Erkrankungen im Kindesalter. Genetik - Umwelteinflüsse - Prädiktion - Prävention. Allergo J 1994; 3: 437-441.
12. Axén R, Drevin H, Kober A, Yman L. A new laboratory diagnostic system applied to allergy testing (Abstract). N Engl Reg Allergy Proc 1988; 9: 503.
13. Yman L. Die neue Generation der Allergie-Testung: Pharmacia CAP System. In vitro Diagnostica Special 1990; 2: 18-22.
14. Borgå Å, Karlsson T, Perborn H, Holmquist I, Lindqvist A, Yman L. Standardization of timothy, peanut and aspergillus fumigatus allergens for immunoassay of specific IgE. J Allergy Clin Immunol 1992; 89: 148-151.
15. Liappis N, Starke A. Evaluation des ImmunoCAP-Systems in der In-vitro-Allergiediagnostik. Allergologie 1997; 20: 291-295.
16. Tahtelä R, Juntunen-Backman K. Evaluation of UniCAP 100 total IgE, specific IgE and ECP assays. XIX Nordic Congress on Allergology, August 10-13, 1996, Helsinki, Finland.
17. Liappis N, Lanito O, Nilsson G, Rydén B. The role of inter-laboratory comparisons in quality improvement of specific IgE measurements with the Pharmacia CAP system RAST RIA and FEIA. Clin Lab 1996; 42: 707-713.
18. Yman L, Ewan P, de Groot H, Lange C, Lindholm N, Paganelli R, Roovers M, Sastre J. Clinical efficiency of UniCAP™ Specific IgE. AAAAI, March 15-20, New Orleans, USA 1996.